The Canadian marijuana stocks on our list have recorded the highest gross margins based on their latest quarter
SmallCapPower | August 21, 2017: Today we have shortlisted four Canadian marijuana stocks that have recorded the highest gross margins based on their latest quarter. They have a market capitalization ranging between $230 million – $905 million.
Aphria Inc (TSX: APH)
Aphria Inc. produces, supplies, and sells medical marijuana. The Company offers cannabis oil with dried marijuana. Aphria operates in Canada. It is a global leader in providing patients with safe and effective medical cannabis products. Their medical cannabis is 100% greenhouse grown.
Aurora Cannabis Inc (TSX: ACB)
Aurora Cannabis Inc. operates in the medical marijuana industry. The Company, through its subsidiaries, is a licensed producer of medical marijuana, and is an active participant in the Cannabis market.
CanniMed Therapeutics Inc (TSX: CMED)
CanniMed Therapeutics Inc. operates as a biopharmaceutical company. The Company focuses on producing pharmaceutical-grade cannabis through research and development, as well as through collaborations with external partners, including academic institutions and healthcare professionals. CanniMed Therapeutics serves the healthcare sector in Canada.
MedReleaf Corp (TSX: LEAF)
MedReleaf Corp. manufactures and distributes medical cannabis. The Company produces and sells dry cannabis, oils, and capsules. It offers products for scientific research and healthcare uses in Canada.
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: